Skip to main content
Nutrigenomics Market Analysis, Size, and Forecast 2024-2028: North America (US and Canada), Europe (France, Germany, UK), APAC (Australia, India, Japan, South Korea), South America (Brazil), and Middle East and Africa (UAE)

Nutrigenomics Market Analysis, Size, and Forecast 2024-2028:
North America (US and Canada), Europe (France, Germany, UK), APAC (Australia, India, Japan, South Korea), South America (Brazil), and Middle East and Africa (UAE)

Published: Apr 2024 162 Pages SKU: IRTNTR40037

Market Overview at a Glance

$997.73 Mn
Market Opportunity
13.87%
CAGR
12.85
YoY growth 2023-2024(%)

Nutrigenomics Market Size 2024-2028

The nutrigenomics market size is forecast to increase by USD 997.73 million, at a CAGR of 13.87% between 2023 and 2028.

  • The market is experiencing significant growth, driven by the increasing cost of medical treatment and the advancements in the nutrigenomics industry. As healthcare expenses continue to rise, there is a growing demand for personalized and preventative healthcare solutions, which nutrigenomics offers through the analysis of the relationship between an individual's genetic makeup and the effect of food on their health. Moreover, the nutrigenomics industry is witnessing rapid developments, with ongoing research and technological advancements leading to new applications and tools for interpreting nutrigenomics datasets.
  • However, the high cost of these tools poses a significant challenge for market growth. Companies seeking to capitalize on market opportunities must focus on developing cost-effective solutions and collaborating with key industry players to access advanced technologies. Navigating this competitive landscape requires a deep understanding of the market dynamics and the ability to adapt to emerging trends and challenges.

What will be the Size of the Nutrigenomics Market during the forecast period?

Nutrigenomics Market Size

 Request Free Sample

The market continues to evolve, driven by advancements in genetic testing and personalized healthcare. This dynamic industry intertwines various sectors, including health coaching, dietary intervention, and direct-to-consumer (dtc) testing. Genetic information is used to provide tailored dietary recommendations based on metabolic pathways, nutrient absorption, and gene expression. Ethical considerations and privacy concerns remain ongoing discussions, as consumer genomics expands. Disease prevention is a significant focus, with nutrigenomics aiding in the identification of food intolerances and sensitivities, as well as personalized approaches to chronic diseases. Precision medicine and lifestyle modification are integral components, with nutrigenomics guiding functional foods and dietary supplement development.

Clinical trials and data analysis play a crucial role in advancing nutrigenomics, providing insights into nutrient metabolism, drug response, and the gut microbiome. Personalized healthcare and wellness programs leverage machine learning and artificial intelligence (AI) to analyze consumer data and deliver customized recommendations. The market's continuous unfolding is shaped by ongoing research and innovation, with applications extending to various industries and sectors. The integration of genetics and nutrition offers a promising future for improving health outcomes and enhancing overall well-being.

How is this Nutrigenomics Industry segmented?

The nutrigenomics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • Application
    • Obesity
    • Cardiovascular diseases
    • Cancer research
    • Diabetes
    • Digestive health
  • Product
    • Reagents and kits
    • Services
    • Software
  • Technology
    • DNA sequencing
    • Microarray analysis
    • PCR.
  • End-User
    • Hospitals
    • Clinics
    • Research institutions
    • Direct-to-consumer
  • Geography
    • North America
      • US
      • Canada
    • Europe
      • France
      • Germany
      • UK
    • Middle East and Africa
      • UAE
    • APAC
      • Australia
      • India
      • Japan
      • South Korea
    • South America
      • Brazil
    • Rest of World (ROW)

    By Application Insights

    The obesity segment is estimated to witness significant growth during the forecast period.

    Genetic testing plays a pivotal role in the market, enabling personalized approaches to disease prevention and health outcomes. However, privacy concerns surrounding genetic information require ethical considerations and counseling. Nutritional genomics explores the relationship between genetics and metabolic pathways, influencing nutrient absorption and metabolism. Precision medicine and lifestyle modification based on nutritional status and gut microbiome analysis are key trends. Functional foods, dietary supplements, and health coaching offer customized solutions for consumers. Genome sequencing and clinical trials contribute to personalized healthcare and chronic disease management.

    Consumer genomics, including food intolerance and wellness programs, are gaining popularity. Machine learning and artificial intelligence facilitate data analysis, enabling personalized nutrition recommendations and drug response predictions. Nutrient metabolism, gene expression, and food sensitivity are essential areas of focus in this evolving market.

    Nutrigenomics Market Size

    Request Free Sample

    The Obesity segment was valued at USD 292.79 million in 2018 and showed a gradual increase during the forecast period.

    Regional Analysis

    North America is estimated to contribute 41% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

    Nutrigenomics Market Share by Geography

     Request Free Sample

    In North America, the market is experiencing significant growth, fueled by a heightened awareness of personalized nutrition and preventative healthcare. With a high prevalence of lifestyle-related diseases such as obesity and diabetes, consumers are increasingly seeking ways to optimize their nutritional intake based on their unique genetic makeup. The region's advanced healthcare technologies and high disposable income further drive demand for nutrigenomics testing services. The US leads the market in North America due to the high number of people suffering from chronic diseases, cancer, and obesity. Nutrigenomics offers the potential to prevent, mitigate, and treat these conditions through targeted dietary changes, making it a valuable tool in the fight against chronic diseases.

    Ethical considerations surrounding genetic testing and privacy concerns are being addressed through rigorous data security measures and genetic counseling services. Metabolic pathways, nutrient absorption, and drug response are key areas of focus in nutrigenomics research, leading to the development of precision medicine and personalized healthcare solutions. Functional foods, nutrient metabolism, and dietary supplements are also gaining popularity as consumers seek to improve their nutritional status and overall health. The gut microbiome, food intolerance, and food sensitivity are also areas of interest in the market, with potential applications in wellness programs and lifestyle modification. Machine learning and artificial intelligence are being employed to analyze consumer data and provide personalized dietary recommendations based on an individual's genetic profile and health goals.

    Clinical trials and personalized nutrition are also key areas of research, with the ultimate goal of improving health outcomes and reducing the burden of chronic diseases.

    Market Dynamics

    Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

    What are the key market drivers leading to the rise in the adoption of Nutrigenomics Industry?

    • The escalating costs of medical treatment serve as the primary market driver. 

    • The market is experiencing significant growth due to the increasing prevalence of diseases and rising healthcare costs. According to the Centers for Disease Control and Prevention (CDC), approximately 610,000 people die of heart disease annually in the US. The escalating burden of these diseases directly impacts overall healthcare expenses, as patients often incur substantial costs on treatment, medication, and hospitalization. The high cost of branded drugs further contributes to medical expenditures, leading many individuals to explore alternative options. In response, there is a growing trend towards precision medicine and lifestyle modification, which includes the consumption of functional foods and nutritional supplements.
    • These products cater to the unique nutritional requirements of individuals based on their genome sequencing and nutrient metabolism. They contain essential nutrients, such as vitamins, proteins, carotenoids, fibers, polyphenols, and probiotics, which positively influence health and drug response. The gut microbiome, a critical component of nutrigenomics, plays a vital role in the absorption and metabolism of these nutrients. As a result, the market for nutrigenomics is expected to continue expanding as more people seek to optimize their health through personalized nutrition.

    What are the market trends shaping the Nutrigenomics Industry?

    • The nutrigenomics industry is experiencing significant advancements, positioning it as the next market trend. This field explores the relationship between genes and nutrition, offering personalized dietary solutions.

    • The market is experiencing notable growth due to the increasing emphasis on personalized healthcare and dietary intervention. Advanced genetic testing technologies, such as next-generation sequencing and microarray analysis, enable accurate assessment of an individual's genetic composition and its interaction with dietary factors. This information leads to personalized nutrition recommendations tailored to each person's unique genetic profile. Recent market developments include Xcode Life's introduction of an extensive gene nutrition test and SomaLogic's collaboration with Citogen to expand the authorized site program across Europe, utilizing SomaLogic's 7,000-plex SomaScan Platform for clinical research, population health studies, and nutrigenomics.
    • These advancements contribute to the market's expansion and highlight the potential for nutrigenomics in addressing chronic diseases through data analysis and personalized dietary recommendations.

    What challenges does the Nutrigenomics Industry face during its growth?

    • The high cost of interpreting nutrigenomics datasets is a significant challenge impeding the growth of the industry. Nutrigenomics, a field of nutritional science that explores the relationship between genes and nutrition, generates vast amounts of complex data. The analysis of this data requires specialized tools and expertise, leading to substantial expenses for companies. Overcoming this financial hurdle is essential for the continued expansion and advancement of the nutrigenomics industry. 

    • Nutrigenomics, the intersection of nutrition and genetics, is revolutionizing the way consumers approach their health and wellness. This field focuses on the impact of food on gene expression and individual responses to specific foods based on their genetic makeup. One significant application of nutrigenomics is in identifying food intolerances and sensitivities. Consumer genomics plays a pivotal role in this market, with companies offering genetic testing services that provide personalized dietary recommendations. For instance, Nutrigenomix Inc. Offers nutrigenomics testing, which includes genotyping, genetic test kits, and customized reports based on the latest research and scientific evidence.
    • However, the high cost of user-friendly tools for interpreting nutrigenomics data is a challenge hindering market growth. Advancements in technology, such as machine learning and artificial intelligence (AI), are helping to address this issue. These technologies enable the analysis of vast amounts of nutrigenomics data, providing insights into food sensitivity and gene expression. For example, specialized software can analyze combined nuclear magnetic resonance (NMR) and mass spectrometry (MS) data sets to identify critical steps for nutrigenomic analysis. Wellness programs are increasingly incorporating nutrigenomics to offer personalized recommendations for their members. As the importance of individualized nutrition becomes more recognized, the market is expected to continue growing.
    • Despite the challenges, the potential benefits of this field make it an exciting area for innovation and development.

    Exclusive Customer Landscape

    The nutrigenomics market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the nutrigenomics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

    Nutrigenomics Market Share by Geography

     Customer Landscape

    Key Companies & Market Insights

    Companies are implementing various strategies, such as strategic alliances, nutrigenomics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

    Nutrigenomix Inc. - The company specializes in nutrigenomics, providing essential vitamins and omega oils for optimal health. Our offerings encompass Vitamin K1, Vitamin A, B-complex Vitamins including B1, B12, and B5, Vitamin D3, Vitamin K2 as MK-7, Vitamin E, and Vegapure plant sterols. These nutrients support various bodily functions, enhancing overall wellness. Our commitment to scientific research underpins the selection and efficacy of each product.

    The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

    • Nutrigenomix Inc.
    • 23andMe Inc.
    • DNAfit
    • GX Sciences Inc.
    • Metagenics Inc.
    • Xcode Life
    • Vitagene
    • Mapmygenome
    • Koninklijke DSM N.V.
    • Danone S.A.
    • BASF SE
    • Nestlé Health Science GenoPalate Inc.
    • GeneOmbio Technologies
    • Holistic Health International
    • Pathway Genomics
    • Cura Integrative Medicine
    • WellGenix
    • Nutrigenetics Unlimited
    • Interleukin Genetics

    Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

    Recent Development and News in Nutrigenomics Market

    • In February 2023, Nestle, a global leader in nutrition, health, and wellness, announced the launch of its new personalized nutrition service, "Nestle Health Science Nutrigenomics," which utilizes nutrigenomics to develop personalized dietary plans based on an individual's genetic makeup (Nestle Press Release, 2023).
    • In March 2024, Thermo Fisher Scientific, a leading biotechnology product developer and provider, entered into a strategic partnership with 23andMe, a consumer genetics and biotechnology company, to integrate Thermo Fisher's SEQüence Suite Bioinformatics Software into 23andMe's nutrigenomics offerings, enhancing the accuracy and accessibility of personalized nutrition recommendations (Thermo Fisher Scientific Press Release, 2024).
    • In June 2024, the European Food Safety Authority (EFSA) granted a positive opinion on the health claim for the nutrigenomic ingredient, OmniGen, developed by Lonza, a Swiss specialty ingredients supplier. This approval marks a significant milestone in the acceptance and regulation of nutrigenomics in the European market (Lonza Press Release, 2024).
    • In November 2025, Danone, a leading global food company, announced a strategic investment of €100 million in NutriLeads, a Danish biotech company specializing in nutrigenomics, to expand its presence in the personalized nutrition market and accelerate the development of novel nutrigenomic ingredients (Danone Press Release, 2025).

    Research Analyst Overview

    • The market encompasses various sectors, including public health initiatives, wearable technology, and the food industry. This market is driven by the integration of nutrigenomic databases and next-generation sequencing (NGS) technologies, enabling personalized dietary plans and health risk assessments. Wearable technology and mobile health (mHealth) platforms facilitate real-time dietary tracking and lifestyle coaching. Precision agriculture and agricultural biotechnology leverage genetic variant analysis and SNP chip arrays to optimize crop production. Data privacy and security are paramount concerns, with regulatory frameworks addressing genetic discrimination and informed consent. Genetic counseling services ensure accurate interpretation of genetic information, while digital health platforms facilitate biodata management and personalized medicine.
    • Mass spectrometry and gene-diet interaction studies further expand the scope of nutrigenomics research. Fitness programs and personalized nutrition products cater to individual needs, while NGS and exome sequencing provide comprehensive genetic information. Data privacy and security are essential in managing sensitive genetic information, with regulatory bodies implementing guidelines to protect consumer data. In the agricultural sector, nutrigenomics applications in precision agriculture and agricultural biotechnology aim to optimize crop yield and nutritional content, ensuring food security and sustainability. The food industry also benefits from nutrigenomics, with personalized dietary plans and nutrition education tailored to individual genetic makeup.
    • Overall, the market continues to evolve, driven by technological advancements and the growing demand for personalized health and wellness solutions.

    Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Nutrigenomics Market insights. See full methodology.

    Market Scope

    Report Coverage

    Details

    Page number

    162

    Base year

    2023

    Historic period

    2018-2022

    Forecast period

    2024-2028

    Growth momentum & CAGR

    Accelerate at a CAGR of 13.87%

    Market growth 2024-2028

    USD 997.73 million

    Market structure

    Fragmented

    YoY growth 2023-2024(%)

    12.85

    Key countries

    US, Canada, UK, France, India, Japan, South Korea, Australia, Germany, UAE, and Brazil

    Competitive landscape

    Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

    Request Free Sample

    What are the Key Data Covered in this Nutrigenomics Market Research and Growth Report?

    • CAGR of the Nutrigenomics industry during the forecast period
    • Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
    • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
    • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
    • Growth of the market across North America, Europe, APAC, South America, and Middle East and Africa
    • Thorough analysis of the market’s competitive landscape and detailed information about companies
    • Comprehensive analysis of factors that will challenge the nutrigenomics market growth of industry companies

    We can help! Our analysts can customize this nutrigenomics market research report to meet your requirements.

    Get in touch

     

    Table of Contents not available.

    Research Methodology

    Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

    INFORMATION SOURCES

    Primary sources

    • Manufacturers and suppliers
    • Channel partners
    • Industry experts
    • Strategic decision makers

    Secondary sources

    • Industry journals and periodicals
    • Government data
    • Financial reports of key industry players
    • Historical data
    • Press releases

    DATA ANALYSIS

    Data Synthesis

    • Collation of data
    • Estimation of key figures
    • Analysis of derived insights

    Data Validation

    • Triangulation with data models
    • Reference against proprietary databases
    • Corroboration with industry experts

    REPORT WRITING

    Qualitative

    • Market drivers
    • Market challenges
    • Market trends
    • Five forces analysis

    Quantitative

    • Market size and forecast
    • Market segmentation
    • Geographical insights
    • Competitive landscape

    Interested in this report?

    Get your sample now to see our research methodology and insights!

    Download Now

    Frequently Asked Questions

    Nutrigenomics market growth will increase by $ 997.73 mn during 2024-2028.

    The Nutrigenomics market is expected to grow at a CAGR of 13.87% during 2024-2028.

    Nutrigenomics market is segmented by Application( Obesity, Cardiovascular diseases, Cancer research, Diabetes, Digestive health) Product( Reagents and kits, Services, Software, Rest of World (ROW))

    Nutrigenomix Inc., 23andMe Inc., DNAfit, GX Sciences Inc., Metagenics Inc., Xcode Life, Vitagene, Mapmygenome, Koninklijke DSM N.V., Danone S.A., BASF SE, Nestlé Health Science GenoPalate Inc., GeneOmbio Technologies, Holistic Health International, Pathway Genomics, Cura Integrative Medicine, WellGenix, Nutrigenetics Unlimited, Interleukin Genetics are a few of the key vendors in the Nutrigenomics market.

    North America will register the highest growth rate of 41% among the other regions. Therefore, the Nutrigenomics market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

    US, Canada, Germany, UK, France, India, Japan, South Korea, Australia, Germany, UAE, Brazil, Rest of World (ROW)

    • Increasing cost of medical treatmentThe increased prevalence of diseases and the rising cost of medical treatment are the major factors leading to the growth of the market. According to the Centers for Disease Control and Prevention (CDC) is the driving factor this market.
    • about 610 is the driving factor this market.
    • 000 people die of heart disease in the US every year. The increasing burden of these diseases has a direct impact on overall healthcare costs is the driving factor this market.
    • as more patients are spending heavily on treatment is the driving factor this market.
    • medicine is the driving factor this market.
    • and hospitals to improve their medical condition. The high cost of branded drugs increases the medical expenditure of patients. Thus is the driving factor this market.
    • many people are opting for dietary supplements and fortified dairy products is the driving factor this market.
    • which contain nutrients is the driving factor this market.
    • such as vitamins is the driving factor this market.
    • proteins is the driving factor this market.
    • carotenoids is the driving factor this market.
    • fibers is the driving factor this market.
    • polyphenols is the driving factor this market.
    • and probiotics is the driving factor this market.
    • based on nutrigenomics. These nutrients help in treating or preventing the occurrence of certain diseases. The high cost of medical treatment is a factor that is compelling for patients to opt for nutrigenomics to treat underlying medical conditions. With nutrigenomics is the driving factor this market.
    • generalized nutrition guidance is given to these individuals. The availability of nutrigenomic technologies to individuals allows them to make better decisions about their nutrition and health. Individuals are increasingly opting for nutrigenomics to control the rising healthcare costs and reduce the increasing burden of diseases and health conditions. There is an increasing need among patients to reduce the high costs associated with frequent hospital visits and treatment is the driving factor this market.
    • particularly among patients who do not have access to advanced healthcare facilities. Thus is the driving factor this market.
    • the demand for nutrigenomics is growing rapidly. This is expected to drive the growth of the global nutrigenomics market during the forecast period. is the driving factor this market.

    The Nutrigenomics market vendors should focus on grabbing business opportunities from the Obesity segment as it accounted for the largest market share in the base year.